1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Global Dog Vaccine
Market Outlook
4.1.
Market Size & Forecast
4.1.1. By Value
4.2.
Market Share & Forecast
4.2.1. By Type (Modified/ Attenuated Live, Inactivated (Killed),
Others)
4.2.2. By Disease Type (Canine Distemper, Canine Infectious
Respiratory Disease Complex (CIRDC), Canine Parvovirosis/ Parvovirus Disease,
Canine Leptospirosis, Canine Lyme Disease, Infectious Canine Hepatitis, Canine
Rabies, Other Diseases)
4.2.3. By Route of Administration (Injectable, Intranasal, Oral)
4.2.4. By Component (Combined Vaccines, Mono Vaccines)
4.2.5. By Region
4.2.6. By Company (2023)
4.3.
Market Map
4.3.1. By Type
4.3.2. By Disease Type
4.3.3. By Route of
Administration
4.3.4. By Component
4.3.5. By Region
5. Asia Pacific Dog
Vaccine Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value
5.2.
Market Share & Forecast
5.2.1. By Type
5.2.2. By Disease Type
5.2.3. By Route of
Administration
5.2.4. By Component
5.2.5. By Country
5.3.
Asia Pacific: Country Analysis
5.3.1. China Dog Vaccine
Market Outlook
5.3.1.1.
Market Size & Forecast
5.3.1.1.1.
By Value
5.3.1.2.
Market Share & Forecast
5.3.1.2.1.
By Type
5.3.1.2.2.
By Disease Type
5.3.1.2.3.
By Route
of Administration
5.3.1.2.4.
By
Component
5.3.2. India Dog Vaccine
Market Outlook
5.3.2.1.
Market Size & Forecast
5.3.2.1.1.
By Value
5.3.2.2.
Market Share & Forecast
5.3.2.2.1.
By Type
5.3.2.2.2.
By Disease Type
5.3.2.2.3.
By Route
of Administration
5.3.2.2.4.
By
Component
5.3.3. Australia Dog
Vaccine Market Outlook
5.3.3.1.
Market Size & Forecast
5.3.3.1.1.
By Value
5.3.3.2.
Market Share & Forecast
5.3.3.2.1.
By Type
5.3.3.2.2.
By Disease Type
5.3.3.2.3.
By Route
of Administration
5.3.3.2.4.
By
Component
5.3.4. Japan Dog Vaccine
Market Outlook
5.3.4.1.
Market Size & Forecast
5.3.4.1.1.
By Value
5.3.4.2.
Market Share & Forecast
5.3.4.2.1.
By Type
5.3.4.2.2.
By Disease Type
5.3.4.2.3.
By Route
of Administration
5.3.4.2.4.
By
Component
5.3.5. South Korea Dog
Vaccine Market Outlook
5.3.5.1.
Market Size & Forecast
5.3.5.1.1.
By Value
5.3.5.2.
Market Share & Forecast
5.3.5.2.1.
By Type
5.3.5.2.2.
By Disease Type
5.3.5.2.3.
By Route
of Administration
5.3.5.2.4.
By
Component
6. Europe Dog Vaccine
Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Type
6.2.2. By Disease Type
6.2.3. By Route of
Administration
6.2.4. By Component
6.2.5.
By
Country
6.3.
Europe: Country Analysis
6.3.1. France Dog Vaccine
Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Type
6.3.1.2.2.
By Disease Type
6.3.1.2.3.
By Route
of Administration
6.3.1.2.4.
By
Component
6.3.2. Germany Dog Vaccine
Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Type
6.3.2.2.2.
By Disease Type
6.3.2.2.3.
By Route
of Administration
6.3.2.2.4.
By
Component
6.3.3. Spain Dog Vaccine
Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Type
6.3.3.2.2.
By Disease Type
6.3.3.2.3.
By Route
of Administration
6.3.3.2.4.
By
Component
6.3.4. Italy Dog Vaccine
Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Type
6.3.4.2.2.
By Disease Type
6.3.4.2.3.
By Route
of Administration
6.3.4.2.4.
By
Component
6.3.5. United Kingdom Dog
Vaccine Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Type
6.3.5.2.2.
By Disease Type
6.3.5.2.3.
By Route
of Administration
6.3.5.2.4.
By
Component
7. North America Dog Vaccine
Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Type
7.2.2. By Disease Type
7.2.3. By Route of Administration
7.2.4. By Component
7.2.5. By Country
7.3.
North America: Country Analysis
7.3.1. United States Dog
Vaccine Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Disease Type
7.3.1.2.3.
By Route
of Administration
7.3.1.2.4.
By
Component
7.3.2. Mexico Dog Vaccine
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Disease Type
7.3.2.2.3.
By Route
of Administration
7.3.2.2.4.
By
Component
7.3.3. Canada Dog Vaccine
Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Disease Type
7.3.3.2.3.
By Route
of Administration
7.3.3.2.4.
By
Component
8. South America Dog
Vaccine Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Type
8.2.2. By Disease Type
8.2.3. By Route of Administration
8.2.4. By Component
8.2.5. By Country
8.3.
South America: Country Analysis
8.3.1. Brazil Dog Vaccine
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Disease Type
8.3.1.2.3.
By Route
of Administration
8.3.1.2.4.
By
Component
8.3.2. Argentina Dog
Vaccine Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Disease Type
8.3.2.2.3.
By Route
of Administration
8.3.2.2.4.
By
Component
8.3.3. Colombia Dog Vaccine
Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Disease Type
8.3.3.2.3.
By Route
of Administration
8.3.3.2.4.
By
Component
9. Middle East and
Africa Dog Vaccine Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Type
9.2.2. By Disease Type
9.2.3. By Route of Administration
9.2.4. By Component
9.2.5. By Country
9.3.
MEA: Country Analysis
9.3.1. South Africa Dog
Vaccine Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Disease Type
9.3.1.2.3.
By Route
of Administration
9.3.1.2.4.
By
Component
9.3.2. Saudi Arabia Dog
Vaccine Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Disease Type
9.3.2.2.3.
By Route
of Administration
9.3.2.2.4.
By
Component
9.3.3. UAE Dog Vaccine
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Disease Type
9.3.3.2.3.
By Route
of Administration
9.3.3.2.4.
By
Component
9.3.4. Egypt Dog Vaccine
Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Type
9.3.4.2.2.
By Disease Type
9.3.4.2.3.
By Route
of Administration
9.3.4.2.4.
By
Component
10. Market Dynamics
10.1.
Drivers
10.2.
Challenges
11. Market Trends &
Developments
11.1.
Recent Developments
11.2.
Product Launches
11.3.
Mergers & Acquisitions
12. Global Dog Vaccine
Market: SWOT Analysis
13. Porter’s Five Forces
Analysis
13.1.
Competition in the Industry
13.2.
Potential of New Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute Product
14. Competitive
Landscape
14.1. Bioveta A.S
14.1.1.
Business Overview
14.1.2.
Company Snapshot
14.1.3.
Products & Services
14.1.4.
Financials (As Reported)
14.1.5.
Recent Developments
14.1.6.
Key Personnel Details
14.1.7.
SWOT Analysis
14.2. Hester Biosciences
Limited
14.3. Boehringer Ingelheim
International GmbH
14.4. Brilliant Bio Pharma Private Limited
14.5. Heska Corporation
14.6. Merck & Co.,
Inc.
14.7. Virbac SACA
14.8. Zendal Group
14.9. Elanco Animal Health Inc
14.10. Zoetis Services LLC.
15. Strategic
Recommendations
16. About Us & Disclaimer